Category:
Active Pharmaceutical Ingredients
CAS NO:
357336-20-0
Standard:
USP/ChP/BP/EP/JP,
Brivaracetam is a potent antiepileptic drug (AED) developed as a high-affinity synaptic vesicle protein 2A (SV2A) ligand. It serves as a next-generation alternative to levetiracetam with improved pharmacokinetic profiles. The core synthesis involves complex organic coupling reactions to ensure pharmaceutical-grade purity.
Molecular Formula: C15H20N2O2Contraindicated in patients with known hypersensitivity. Strict storage required at controlled room temperature (20-25°C) in moisture-proof containers. Clinical use mandates monitoring for psychiatric adverse events and potential drug-drug interactions.